Pancreatic Cancer Research

ResearcherYale New Haven HospitalActive in the last 2 years

Nita Ahuja

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8293-1893; OpenAlex author ID A5114001695. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
2
Collaborators
64
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. SPINK1-COL18A1 crosstalk shapes epigenome and drives cancer stemness in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.celrep.2026.117806↗
  2. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis. Co-author DOI 10.1053/j.gastro.2021.11.021↗
  3. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Co-author DOI 10.1186/s13148-022-01367-8↗
  4. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001919↗
  5. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival. Co-author DOI 10.1001/jamasurg.2019.5047↗
  6. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Last author DOI 10.1186/s13148-019-0650-0↗
  7. The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer. First author DOI 10.3390/cancers11121859↗
  8. Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Co-author DOI 10.1002/cam4.1104↗
  9. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer. Co-author DOI 10.18632/oncotarget.15722↗
  10. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2015.10.010↗
  11. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000001600↗
  12. Early detection of pancreatic cancer. First author DOI 10.3978/j.issn.1000-9604.2015.07.03↗
  13. Young patients undergoing resection of pancreatic cancer fare better than their older counterparts. Co-author DOI 10.1007/s11605-012-2066-4↗
  14. Novel methylation biomarker panel for the early detection of pancreatic cancer. Last author DOI 10.1158/1078-0432.ccr-12-3224↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher Lee Wolfgang · 8 shared papers, 2013–2026 · strength 0.60
  2. Christine A. Iacobuzio–Donahue · 6 shared papers, 2013–2026 · strength 0.50
  3. Laura DeLong Wood · 5 shared papers, 2016–2026 · strength 0.49
  4. Ankit Chhoda · 3 shared papers, 2021–2026 · strength 0.47
  5. John W. Kunstman · 3 shared papers, 2020–2026 · strength 0.47
  6. Nesrin M. Hasan · 3 shared papers, 2019–2021 · strength 0.38
  7. James J. Farrell · 2 shared papers, 2021–2022 · strength 0.26
  8. Ralph H. Hruban · 5 shared papers, 2013–2019 · strength 0.25
  9. Md Shahadat Hossan · 1 shared paper, 2026 · strength 0.21
  10. Haoyu Tang · 1 shared paper, 2026 · strength 0.21
  11. Saryn Doucette · 1 shared paper, 2026 · strength 0.21
  12. Jeremy D. Kratz · 1 shared paper, 2026 · strength 0.21
  13. Jin Peng He · 4 shared papers, 2013–2019 · strength 0.20
  14. Joseph M. Herman · 4 shared papers, 2013–2017 · strength 0.18
  15. Nilofer Saba Azad · 2 shared papers, 2017–2022 · strength 0.18
  16. Victoria Kim · 2 shared papers, 2015–2017 · strength 0.15
  17. Fay Kastrinos · 1 shared paper, 2022 · strength 0.15
  18. Danielle R. Heller · 1 shared paper, 2020 · strength 0.15
  19. Norman G. Nicolson · 1 shared paper, 2020 · strength 0.15
  20. Matthew John Weiss · 3 shared papers, 2016–2017 · strength 0.14
  21. Peter James O'Dwyer · 1 shared paper, 2022 · strength 0.13
  22. Dulabh Kaur Monga · 1 shared paper, 2022 · strength 0.13
  23. Marina Baretti · 1 shared paper, 2022 · strength 0.13
  24. Thatcher Ross Heumann · 1 shared paper, 2022 · strength 0.13
  25. Colin D. Weekes · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.